How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Biotheryx Announces First Patient Dosed in the Dose Expansion Phase of BTX-9341-101 for the Treatment of HR+/HER2- Breast Cancer

calendar_today March 18, 2026 person biotheryx domain biotheryx

SAN DIEGO, CA, March 18, 2026 – Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class[…] Read More

open_in_new Read original post